Use of low titer O whole blood in infants and young children undergoing cardiac surgery with cardiopulmonary bypass.

Massimo GriselliSameh M Said Philip C SpinellaMichael EvansClaudia S CohnNitasha JoynerMartina RichtsfeldKayla Fahey-ArndtJulie WelbigGreg BeilmanNicole D ZantekMarie E Steiner

Published in: Transfusion (2024)

The use of LTOWB appears to be safe in <2 years old undergoing cardiac surgery and may reduce re-explorations for severe bleeding. Large trials are needed to determine the efficacy and safety of LTOWB in this population with severe bleeding.

Keyphrases

cardiac surgery
acute kidney injury
atrial fibrillation
early onset
drug induced